ECHO for Diabetes and Multiple Chronic Conditions Study

NAEnrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

June 30, 2028

Conditions
Diabetes MellitusChronic Disease
Interventions
BEHAVIORAL

ECHO program for DMMC

For the intervention, an 18-month ECHO program of weekly videoconference sessions will mentor healthcare teams on complex care strategies for patients with DMMC, emphasizing evidence-based best practices related to common chronic conditions (e.g., diabetes, CKD, hypertension, hyperlipidemia and depression). Mentorship will be provided by a multidisciplinary team of experts including a patient representative, diabetes educator, endocrinologist, psychiatrist, a nephrologist/kidney disease and hypertension specialist, a clinical pharmacist, and a cardiology consultant. Each session will consist of a didactic presentation, de-identified patient case presentations, and questions and discussion.

BEHAVIORAL

Usual care

The comparator will consist of 10 PMS FQHC clinics with healthcare teams practicing usual care according to PMS standard practices during the 18 months of the intervention arm.

Trial Locations (1)

87501

Presbyterian Medical Services, Santa Fe

Sponsors
All Listed Sponsors
collaborator

Presbyterian Medical Services

UNKNOWN

collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

University of New Mexico

OTHER

NCT06451458 - ECHO for Diabetes and Multiple Chronic Conditions Study | Biotech Hunter | Biotech Hunter